Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020)
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index; 1 of the 8 sources its claims cite were checked for support.
Abstract
The systemic immunity-inflammation index (SII) is a novel inflammatory marker, and aberrant blood lipid levels are linked to inflammation. This study aimed to look at the probable link between SII and hyperlipidemia. The current cross-sectional investigation was carried out among people with complete SII and hyperlipidemia data from the 2015–2020 National Health and Nutrition Examination Survey (NHANES). SII was computed by dividing the platelet count × the neutrophil count/the lymphocyte count. The National Cholesterol Education Program standards were used to define hyperlipidemia. The nonlinear association between SII and hyperlipidemia was described using fitted smoothing curves and threshold effect analyses. A total of 6117 US adults were included in our study. A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis. Age, sex, body mass index, smoking status, hypertension, and diabetes were not significantly correlated with this positive connection, according to subgroup analysis and interaction testing (p for interaction > 0.05). Additionally, we discovered a non-linear association between SII and hyperlipidemia with an inflection point of 479.15 using a two-segment linear regression model. Our findings suggest a significant association between SII levels and hyperlipidemia. More large-scale prospective studies are needed to investigate the role of SII in hyperlipidemia.
Overview
CoChat Summary
TL;DR
In a cross-sectional NHANES 2015–2020 sample of 6,117 US adults, higher systemic immunity-inflammation index (SII) was associated with higher odds of hyperlipidemia in minimally and partially adjusted models. The association was nonlinear, with an inflection point at SII 479.15, and became statistically insignificant in the fully adjusted model.
Key findings
- Among 6,117 participants, mean SII was 459.54 ± 317.28, mean age was 50.70 ± 17.43 years, 48.08% were male, and 69.72% had hyperlipidemia.
- SII/100 was positively associated with hyperlipidemia in model 1 [OR 1.04 (1.02, 1.06)] and model 2 [OR 1.03 (1.01, 1.05)], but not in fully adjusted model 3 [OR 1.02 (1.00, 1.04)].
- In SII quartile sensitivity analysis using model 2, Quartile 4 was associated with a 27.04% increased risk of hyperlipidemia versus Quartile 1 (p for trend < 0.05).
- A nonlinear association was found with an inflection point of 479.15; in women, an inverted U-shaped curve had an inflection point of 958.14. Subgroup interaction tests were not significant (p for interaction > 0.05).
Methods
- Cross-sectional study using NHANES 2015–2020 data; from 25,531 eligible people, exclusions for missing SII data (5,264), missing hyperlipidemia data (12,969), and age <20 years (1,181) yielded 6,117 participants.
- SII was calculated as platelet count × neutrophil count / lymphocyte count; hyperlipidemia was defined by NCEP ATP III criteria or reported use of cholesterol-lowering drugs.
- Multivariable logistic regression with three adjustment models, smooth curve fitting, threshold effect analysis, and subgroup/interaction testing; analyses used R and EmpowerStats with weighting.
Limitations
- The authors state that the cross-sectional design cannot establish causation and that prospective studies are needed.
- The authors state that residual confounding may remain, including long-term medication use such as steroids, which was not recorded in NHANES; they also note that the inflammation–disease interaction is complex and generalization may be improper.
- Evident from the text: the fully adjusted model 3 did not retain statistical significance, and the abstract describes “multivariate linear regression” while the Methods/Results describe multivariable logistic regression.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 3 Not checked · 21 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SII was shown to correlate significantly with hyperlipidemia in subgroups stratified by sex, BMI, and diabetes (p < 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction tests revealed that the relationship between SII and hyperlipidemia was not statistically different across strata, showing that age, sex, BMI, smoking status, hypertension, and diabetes did not significantly impact this positive correlation (p for interaction> 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, in model 3, the positive association between SII and hyperlipidemia became insignificant (1.02 (1.00, 1.04)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
- Also stated in: § Abstract · plain
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an associationn = 6,117 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
8 more claims
Create a free account to see all 25 claims and to verify the 7 references still open.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 6
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To minimize the influence of highly variable MHR values, MHR was scaled by multiplying by 10 (19).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“The systemic immunity-inflammation index is the dependent variable in this investigation.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“SII was intended as an exposure variable in our research.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > Abstract
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.4. Statistical Analysis
“To examine the association between SII and hyperlipidemia, multivariate logistic regression analysis between SII and hyperlipidemia was used”
Citations
Cites
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · cited 1×
“Adult Treatment Panel III (ATP 3) of the National Cholesterol Education Program (NCEP) classified hyperlipidemia as total cholesterol 200 mg/dL, triglycerides 150 mg/dL, HDL 40 mg/dL in males and 50 mg/dL in females, or low-density lipoprotein 130 mg/dL [21].”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · cited 1×
“In the United States, 28 million people had total cholesterol levels higher than 240 mg/dL [4].”
BackgroundHeart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797 · cited 1×
“In addition, hyperlipidemia significantly increases the risk of cardiovascular and immune diseases and is a significant cause of stroke and death [5].”
BackgroundTarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412 · cited 1×
“described infantile-onset STING-associated vasculopathy caused by a systemic gain-of-function mutation in the TMEM173 gene and in patients characterized by systemic inflammation [37,38].”
BackgroundSelf-citationResolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“The ability of SPM to limit leukocyte infiltration and counter-regulate the production of pro-inflammatory mediators is one of its main biological functions [44].”
BackgroundInflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184 · cited 1×
“The interaction between systemic inflammation and the local immune response has been identified as the seventh cancer hallmark, and it has been shown to be involved in the initiation, development, and progression of various forms of cancer [11,12].”
Background
Cited by
Wu, C., Wu, C.-H., Lee, C., & Cheng, C. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03316-6 · Cited by 131
“htm) or a serum total cholesterol level ≥ 200 mg/dL, HDL-c < 40 mg/dl for men, HDL-c < 50 mg/dl for women, LDL-c ≥ 130 mg/dl, or triglyceride ≥ 150 mg/dl [20].”
Ma, R., Cui, L., Cai, J., Yang, N., Wang, Y., Chen, Q., Chen, W., Peng, C., Qin, H., Ding, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1323174 · Cited by 130
Liu, K., Tang, S., Liu, C., Ma, J., Cao, X., Yang, X., Zhu, Y., Chen, K., Liu, Y., Zhang, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337241 · Cited by 133
Self-citationAssociation between systemic immune-inflammation index and cardiovascular-kidney-metabolic syndrome
Gao, C., Gao, S., Zhao, R., Shen, P., Zhu, X., Yang, Y., Duan, C., Wang, Y., Ni, H., Zhou, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69819-0 · Cited by 127
“Inflammation also lowers HDL cholesterol by impairing its anti-inflammatory and cholesterol transport functions 22,23 .”
BackgroundZhao, E., Cheng, Y., Yu, C., Li, H., & Fan, X. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2197652 · Cited by 80
Wei, X., Zhang, Z., Wei, J., & Luo, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1248655 · Cited by 72
“Nevertheless, several cross-sectional studies have found significant associations between SII and hypertension (30), hyperlipidemia (31), and abdominal aortic calcification (32).”
The association between systemic inflammation markers and the prevalence of hypertension
Jin, N., Huang, L., Hong, J., Zhao, X., Hu, J., Wang, S., Chen, X., Rong, J., & Lu, Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03661-6 · Cited by 66
“Despite the observed association between SII and hypertension, as well as blood pressure [14, 15], there is currently a lack of research investigating the correlation between SIRI, AISI and hypertension, as well as no studies that concurrently compare these three systemic inflammation markers.”
BackgroundZhou, Y., Wang, Y., Wu, T., Zhang, A., & Li, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02240-8 · Cited by 57
“Research indicates that elevated SII levels are linked to metabolic syndrome [20], hyperlipidemia [32], diabetic nephropathy [33], and non-alcoholic fatty liver disease (NAFLD) [34].”
BackgroundHan, Y., Jiang, X., Qin, Y., Zhao, Y., Zhang, G., & Liu, C. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01908-x · Cited by 48
“Moreover, participants who reported using lipid-lowering medications were considered to have hyperlipidemia [13, 14].”
BackgroundSelf-citationLi, Z., Zhang, L., Yang, Q., Zhou, X., Yang, M., Zhang, Y., & Li, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-17925-z · Cited by 48
“Some studies have reported potentially protective effects of dietary quality on depression symptoms, as well as the biological actions of nutrients [4].”
BackgroundMethodKarakayalı, M., Omar, T., Artaç, İ., Rencüzoğulları, İ., Karabağ, Y., & Demir, Ö. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14688 · Cited by 44
Chen, Y., Li, Y., Liu, M., Xu, W., Tong, S., & Liu, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-56387-6 · Cited by 34
“…triglycerides, uric acid, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, calcium, cholesterol, creatinine, glucose, triglycerides, uric acid, sodium ,potassium,globulin,albumin 8,9,17–19 .”
Gong, H., He, Q., Zhu, L., Feng, Z., Sun, M., Jiang, J., Yuan, X., Shen, Y., & Di, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1389967 · Cited by 38
Liu, J., Wang, H., Liu, Q., Long, S., Wu, Y., Wang, N., Lin, W. S., Chen, G., Lin, M., & Wen, J. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01226-4 · Cited by 35
“The following equations were used to calculate SII, PIV, SIRI, NLR, MLR, and PLR according to previous studies [48–51].”
MethodLiu, X., Li, X., Chen, Y., Liu, X., Liu, Y., Wei, H., & Li, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331610 · Cited by 34
Self-citationChen, Z., Cheang, I., Zhu, X., Qu, Q., Chen, S., Xing, Y., Zhou, Y., Zhang, H., & Li, X. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16346 · Cited by 31
Association between systemic immune-inflammation index and insulin resistance and mortality
Deng, X., Liu, D., Li, M., He, J., & Fu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-51878-y · Cited by 30
Cao, S., & Hu, Y. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00802-2 · Cited by 28
“Systemic immune-inflammatory index (SII) was calculated as platelet count multiplied by neutrophil count divided by lymphocyte count as described by Mahemuti N et al. [26].”
MethodGuo, Z., Zheng, Y., Jian, G., Wu, Z., Wei, T., Shan, G., Zhu, Y.-H., Zheng, Y., & Li, X. (2023) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2023.11.004 · Cited by 27
“Accumulating evidence has proven the associations of increased SIRI, SII, and PIV levels with the increased risks of chronic disease such as CVD [14], hyperlipidemia [15] and hepatic steatosis [16].”
Ramezankhani, A., Tohidi, M., & Hadaegh, F. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02629-4 · Cited by 28
“Details of the study have been described previously [23].”
Wang, R., Tao, W., Chen, H., Ma, T., & Cheng, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-75111-y · Cited by 27
Wang, M., Peng, C., Jiang, T., Wu, Q., Li, D., & Lu, M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1330338 · Cited by 26
Structural and pharmacological insights into cordycepin for neoplasms and metabolic disorders
Zhang, J., Yang, Z., Zhao, Z., & Zhang, N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367820 · Cited by 35
Self-citationChaoqun, L., Zhang, C., Song, J., Yan, L., Xiao, Y., Cheng, N., Wu, H., Chen, X., & Yang, J. (2024) · BMC Cancer · doi:10.1186/s12885-024-12448-7 · Cited by 25
“Given the significant prevalence of comorbidity among cancer survivors [56], chronic cardiovascular and endocrine conditions can influence an individual’s inflammation and nutritional status [57, 58], potentially affecting the predictive capability of NPS for cancer disease.”
BackgroundNiu, Z., Chen, T., Duan, Z., Han, S., Shi, Y., Yu, W., Du, S., Tang, H., Shao, W., Sun, J., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117269 · Cited by 25
Yan, P., Yang, Y., Zhang, X., Zhang, Y., Li, J., Wu, Z., Dan, X., Wu, X., Chen, X., Li, S., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1307692 · Cited by 26
Zhou, H., Li, T., Li, J., Zheng, D., Yang, J., & Zhuang, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1365580 · Cited by 23
Wang, R., Cheng, X., & Tao, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1362667 · Cited by 23
Hu, S., Song, J., Jiang, H., Wei, B., & Wang, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1591799 · Cited by 22
Yan, S., Luo, W., Lei, L., Zhang, Q., & Xiu, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1280873 · Cited by 23
Shi, C., Cao, H., Zeng, G., Yang, L., & Wang, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306860 · Cited by 22
“Body mass index (BMI) was stratified into three groups: 25.0, 25.0–30.0, and � 30 kg/m2 [25].”
MethodInfluentialZeng, P., Jiang, C. S., Liu, A., Yang, X., Lin, F., & Cheng, L. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04635-1 · Cited by 23
“Previous studies have reported an inverted U-shaped relationship between SII and hyperlipidemia [53].”
BackgroundLi, L., Chen, K., Wen, C., Ma, X., & Huang, L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0292646 · Cited by 24
Liang, H., Si, W., Lin, L., & Yang, K. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1501722 · Cited by 21
“The NHANES is a comprehensive, population-based survey research project sponsored by the National Center for Health Statistics (20, 21).”
MethodAssociation of two novel systemic inflammatory biomarkers and frailty based on NHANES 2007–2018
Zhang, H., Liu, X., Wang, X., & Jiang, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1377408 · Cited by 20
Chu, Z., Zeng, L., Yang, F., Hu, Z., Luo, Y., Zhou, Y., Tang, Y., & Luo, F. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104306 · Cited by 20
Wu, J., & Guo, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309150 · Cited by 20
“This dataset encompasses a wide array of information, including potential risk factors and nutrient levels, providing a comprehensive exploration of factors influencing the health of the U.S. population [24].”
BackgroundHuang, Y., Liao, J., & Liu, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1222636 · Cited by 19
Self-citationYi, C., Zhou, Y.-N., Guo, J. F., Chen, J., & She, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1399150 · Cited by 20
Self-citationXie, F., Yu, Z., Xiong, Y., Wu, Z., & Wu, Y. (2024) · European journal of medical research · doi:10.1186/s40001-024-01736-4 · Cited by 21
“Moreover, recent evidence also indicates that higher levels of SII are correlated with a higher risk of hyper-lipidemia (OR = 1.02; 95% CI 1.00–1.04) and diabetes (OR = 2.024; 95% CI 1.297–3.157) [34, 35].”
BackgroundInfluentialLa, R., Yin, Y., Ding, W., He, Z., Lu, L., Xu, B., Jiang, D., Huang, L., Jiang, J. C., Zhou, L., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02154-5 · Cited by 19
“Furthermore, individuals reporting current use of cholesterol-lowering medications were also considered to have hyperlipidemia [18, 24].”
BackgroundShi, R. H., Tian, Y., Tian, J., Liu, Q., Zhang, J., Zhang, Z., Sun, Y., & Xie, Z. (2025) · Scientific Reports · doi:10.1038/s41598-024-83073-4 · Cited by 19
Stephenson, S. S., Kravchenko, G., Korycka-Błoch, R., Kostka, T., & Sołtysik, B. K. (2024) · Nutrients · doi:10.3390/nu16152464 · Cited by 17
Wang, Y., Zhao, S.-Y., Wang, Y., Xu, J., & Wang, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-68347-1 · Cited by 18
Wang, R., Chen, R., Tao, W., & Cheng, X. (2025) · BMC Public Health · doi:10.1186/s12889-025-24320-9 · Cited by 17
“…if they had consumed more than one hundred cigarettes in a year [17] and defined hyperlipidemia as a total cholesterol level ≥ 200 mg/dL, triglycerides level ≥ 150 mg/dL, high-density lipoprotein level ≤ 40 mg/dL in men and ≤ 50 mg/dL in women, or ≥ 130 mg/dL of low-density lipoprotein [18, 19].”
Zhou, Y., Luo, Z., Yu, M., Zhan, C., Xu, H., Lin, R., Bian, S., Yang, Y., Jiang, Z., Tao, X., et al. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s433488 · Cited by 16
“22,23”
Geng, C., & Chen, C. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07654-x · Cited by 18
Association between systemic immune-inflammation index and cataract among outpatient US adults
Huang, J., Wu, H., Yu, F., Wu, F., Hang, C., Zhang, X., Hao, Y., Fu, H., Xu, H., Li, R., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1469200 · Cited by 16
“Specifically, the SII is derived from these three types of circulating immune cells (12, 13).”
BackgroundLiu, X., Wang, Y., Huang, Y., Lin, C., Xu, B., Zeng, Y., Chen, P., Liu, X., & Huang, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-13760-6 · Cited by 17
“Hyperlipidemia was defined by any of the following criteria: use of lipid-lowering medications, hypertriglyceridemia (triglycerides ≥ 150 mg/dL), or hypercholesterolemia (total cholesterol ≥ 200 mg/dL, LDL ≥ 130 mg/dL, or HDL 40 mg/dL) [35].”
(2024) · doi:10.3389/fpsyt.2024.1442954 · Cited by 15
Yang, C., Liu, Z., Zhang, L., & Gao, J. (2024) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00660-x · Cited by 15
“The SII index was calculated as: The SII index ( × 10 9 /L) = neutrophil count ( × 10 9 /L)/lymphocyte count ( × 10 9 /L) × platelet count ( × 10 9 /L) [13].”
Huang, Y., Yin, X., & Li, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-02929-1 · Cited by 15
“Secondly, inflammation diminishes HDL cholesterol by compromising its anti-inflammatory and cholesterol transport capabilities [24, 25].”
Gou, R., Xiong, S., Liang, X., Wu, H., Qin, S., Li, B., Luo, C., & Chen, J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1380464 · Cited by 15
Self-citationQiu, L., Ren, Y., Li, J., Li, M., Li, W., Qin, L., Ning, C., Zhang, J., & Gao, F. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.06.003 · Cited by 14
Zhao, M., Zhang, D., Zhang, Q., Lin, Y., & Cao, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-66922-0 · Cited by 15
“Additionally, participants who reported using cholesterol-lowering medications were also classified as having hyperlipidemia 28,29 .”
BackgroundMethodLiu, X., Zhang, Y., Li, Y., Sang, Y., Chai, Y., Zhang, L., & Zhang, H. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01725-y · Cited by 14
Yang, S., Zhang, S., Deng, J., Xie, J., Zhang, J., & Jia, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-73659-3 · Cited by 15
“Mahemuti and colleagues previously reported a heightened prevalence of hyperlipidemia in association with elevated SII levels within a cross-sectional study involving adult individuals in the United States 31 .”
BackgroundAssociation of METS-IR index with psoriasis in US adults: a cross-sectional study
Liu, H., Liu, C., Wang, T., & Fang, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-77784-x · Cited by 14
“Diabetes mellitus was defined as meeting any of the following criteria: glycosylated hemoglobin ≥ 6.5%, fasting blood glucose ≥ 7.0 mmol/L (126 mg/dL), self-reported physician diagnosis, or self-reported use of insulin 18 .”
BackgroundInfluentialSelf-citationLi, B., Hou, X., Ning, B., Li, X., Zhang, M., Wang, J., Liu, M., Shi, Y., & Kang, Z. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313503 · Cited by 14
“The SII was calculated as the platelet count multiplied by the neutrophil count divided by the lymphocyte count [22].”
Wu, S., Liu, Z., Li, X., Gao, S., Si, Z., Chen, Q., & Xia, P. (2025) · BMC Public Health · doi:10.1186/s12889-025-21423-1 · Cited by 17
“After participants were enrolled in the study, blood samples were collected on mobile examination centers and then blood cell counts were measured by the automated hematological analyzer (a CoulterDxH 800 analyzer) [20, 21].”
Szymańska, P., Luzak, B., Siarkiewicz, P., & Golański, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914914 · Cited by 16
“Mahemuti et al. found that an increase in SII value correlates with hyperlipidemia [33].”
BackgroundChang, S.-J., Xu, H.-W., Zhang, S., Liu, X., Yi, Y., & Wang, S. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02709-0 · Cited by 14
Xu, R., & Jiang, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1572089 · Cited by 13
Ma, Y. F., Ju, Y., Cao, M., Yang, D., Zhang, K., Liang, H., & Leng, J. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04604-8 · Cited by 16
“It is often used as a predictor of malignancies [9], metabolic disorders [10] and cardio-cerebral events [11, 12].”
BackgroundWang, R., Tao, W., & Cheng, X. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1379871 · Cited by 14
Zheng, Y., Guo, Z., Wang, J., Wu, Z., Chen, X., Zhu, Y.-H., Shan, G., Hou, H., & Li, X. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02912-6 · Cited by 13
“Previous studies have established the correlations between these indicators and non-communicable diseases (NCDs) such as cognitive decline [10], coronary artery disease [11], hyperlipidemia [12], hepatocellular carcinoma [13], and gastric cancer [14, 15].”
Li, H., Sun, W., Fu, S., Wang, J., Jin, B., Zhang, S., Liu, Y., Zhang, Q., & Wang, H. (2025) · BMC Cancer · doi:10.1186/s12885-025-13828-3 · Cited by 13
Self-citationZhang, X., Yang, L., Jin, Z., Li, W., Xiang, H., Wang, W., & Liang, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-14116-7 · Cited by 13
“Diabetes was defined by self-reported diagnosis, medication use, or elevated glucose/HbA1c levels 25 .”
Association between dietary folate intake and HPV infection: NHANES 2005–2016
Jin, S., Lin, F., Yang, L., & Zhang, Q. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306636 · Cited by 12
Chen, D., Chen, F., Luo, Q., Fan, W., Chen, C., & Liu, G. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1363 · Cited by 14
“10 STING pathway activation and HDL ‐ related inflammatory may be potential mechanisms affected the association.”
BackgroundAssociation between systemic immune inflammation index and cataract incidence from 2005 to 2008
Li, X., Du, G.-L., Wu, S., Sun, Y., Zhang, S., Zhang, Z., & Tang, J. (2025) · Scientific Reports · doi:10.1038/s41598-024-84204-7 · Cited by 12
Jiang, Y., & Shen, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1478825 · Cited by 12
“Dyslipidemia was indicated by meeting one of the following five criteria: serum total cholesterol (TC) ≥ 200 mg/dL, TG ≥ 150 mg/dL, LDL-C ≥ 130 mg/dL, HDL-C ≤ 40 mg/dL (males)/ ≤ 50 mg/dL (females), or self-reported cholesterol-lowering medication use (22, 23).”
Association between pan-immune-inflammation value and dyslipidemia in the United States population
Yan, Y., Jia, S., Huo, X., Liu, L., Sun, L., Ma, S., & Chen, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1518304 · Cited by 12
Gan, C., Yao, S., Zhao, J., Shi, H., Xu, J., Zhang, M., & Cheng, H. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03674-7 · Cited by 13
“Unlike some markers affected by fluid imbalances [42], SII provided a stable representation of inflammatory pathways [43].”
Nie, J., Hu, Z., Xian, C., He, M., Lu, D., & Zhang, W. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1356459 · Cited by 12
“As researchers have gradually recognized the importance of SII, an increasing number of reports have shown that SII is associated with many human health problems, such as hypertension (3), diabetes (4), and hyperlipidemia (5).”
BackgroundWang, Y., Liao, L., Guo, Q., Liao, Y., Lin, X., Li, H., Deng, L., Deng, Y., Guo, D., Chen, K., et al. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2396459 · Cited by 11
“…considered to be indicated by total cholesterol ≥ 200 mg/dl, triglycerides ≥ 150 mg/dl, high-density lipoprotein ≤ 40 mg/ dl for men and ≤ 50 mg/dl for women, or a low-density lipoprotein ≥ 130 mg/dl [13]. additionally, people using antilipid-emic medication were considered to have hyperlipidemia.”
BackgroundHao, W., Huang, X., Liang, R., Yang, C., Huang, Z., Chen, Y., Lu, W. W., & Chen, Y. (2024) · Nutrition · doi:10.1016/j.nut.2024.112628 · Cited by 12
The association between statin use and depression in diabetes
Li, Q., Wu, H., Cao, X., Tang, S., & Zhao, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.013 · Cited by 11
Liu, J., Li, J., Xia, C., He, W., Li, X., Shen, S., Zhou, X., Tong, N., & Peng, L. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02208-z · Cited by 11
Association between systemic immunity-inflammation index and psoriasis among outpatient US adults
Ding, Q., Li, X., Lin, L., Xie, X., Jing, W., Chen, X., Chen, J., & Lu, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368727 · Cited by 11
Self-citationHe, M., Du, X.-J., & Liu, Y.-M. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03612-9 · Cited by 10
Self-citationLi, Q., Li, M., Zhao, C., Chen, X., Zhang, C., Li, Y., Chen, Y., & Yue, C. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s523131 · Cited by 10
“11 It has been reported that SII demonstrates superior diagnostic performance for PE compared to the Neutrophil-Lymphocyte Ratio (NLR) or the Monocyte-Lymphocyte Ratio (MLR).”
Zhong, L., Zhan, X., & Luo, X. (2023) · Medicine · doi:10.1097/md.0000000000035724 · Cited by 12
“[11,12] Depression and hyperlipidemia could, to some extent, affect male erectile function.”
BackgroundAlthaher, A. R., Alwahsh, M., Hasan, A., Al-Majali, D., Awadallah, M. W., & Al‐Qirim, T. M. (2024) · Applied Sciences · doi:10.3390/app14199017 · Cited by 10
Systemic Inflammation Indices, Chemokines, and Metabolic Markers in Perimenopausal Women
Cybulska, A. M., Rachubińska, K., Grochans, E., Bosiacki, M., Simińska, D., Korbecki, J., Lubkowska, A., Pańczyk, M., Kuczyńska, M., & Schneider-Matyka, D. (2025) · Nutrients · doi:10.3390/nu17172885 · Cited by 12
“Previous studies have shown that SII and SIRI may serve as independent prognostic markers in cancer [18], rheumatoid arthritis [19], hepatic steatosis [20], diabetes [21], hyperlipidemia [17], acute ischemic stroke [22], cardiovascular risk [23], and metabolic syndrome [24].”
Aljuraiban, G. S., Alharbi, F. J., Aljohi, A. O., Almeshari, A. Z., Alsahli, A. S., Alotaibi, B. S., Abudawood, M., Alfawaz, W., & Abulmeaty, M. M. A. (2024) · Medicine · doi:10.1097/md.0000000000038810 · Cited by 9
“A cross-sectional study also pulling from NHANES data found a significant positive correlation between SII and dyslipidemia, [15] and a study that incorporated aspects of dyslipidemia in the definition of metabolic syndrome also found a positive relationship.”
BackgroundResultPecci, F., Cognigni, V., Giudice, G. C., Paoloni, F., Cantini, L., Saini, K. S., Abushukair, H. M., Naqash, A. R., Cortellini, A., Mazzaschi, G., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104654 · Cited by 11
Jin, X., Liu, Y., Jia, W., Xu, R., Guan, X., Cui, M., Zhang, H., Wu, H., Wei, L., & Qi, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s507696 · Cited by 9
Self-citationZhou, R., Wang, Y., Chen, S., Cheng, F., Yi, Y., Lv, C., & Qin, S. (2025) · Antioxidants · doi:10.3390/antiox14040432 · Cited by 9
“Chronic diseases such as obesity can give rise to hyperlipidemia, cause abnormal blood lipid levels, and thus trigger inflammation [40,41].”
Wang, K., Lu, T., Yang, R., & Zhou, S. (2024) · Nutrients · doi:10.3390/nu16101534 · Cited by 9
“…of the following conditions was diagnosed as hyperlipemia: (i) total cholesterol ≥ 5.2 mmol/L; (ii) triglyceride ≥ 1.7 mmol/L; (iii) low-density lipoprotein ≥ 3.4 mmol/L; (iv) high-density lipoprotein ≤ 1.3 mmol/L for women and ≤ 1.0 mmol/L for men; (v) or use of cholesterol-lowering drugs [29].”
BackgroundInfluentialHuang, Y., Zhou, A., Huang, Y., Wang, Y., Liu, X., & Liu, X. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1505066 · Cited by 8
Association between systemic inflammatory response index and glaucoma incidence from 2005 to 2008
Li, X., Sun, Y., Zhong, X., Zhang, Z. J., Tang, J., & Luo, Z. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1542073 · Cited by 9
Chen, Y., Zhao, J., Li, C., Yao, Y., & Yazhen, S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050372100250512054404 · Cited by 8
Self-citationChen, W., Sun, X., Han, J., Wu, X. O., Wang, Q., Li, M., Lei, X., Wu, Y., Li, Z., Luo, G., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301300 · Cited by 9
“SII is calculated as platelet count x neutrophil count/lymphocyte count [10].”
BackgroundMethodInfluentialChen, J., Zhang, Y., Wu, R., Li, Z., Zhang, T., Yang, X., & Lü, M. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.142626 · Cited by 8
Self-citationAssociation between sleep and tinnitus in US adults: Data from the NHANES (2007–2012)
Wang, C., Li, S., Shi, M., Qin, Z., Wang, D. J., Li, W., Wang, R., Xie, L., & Li, Y. (2024) · Medicine · doi:10.1097/md.0000000000040303 · Cited by 8
“[15] The diagnostic criteria for diabetes mellitus included: a doctor’s diagnosis of diabetes, a glycohemoglobin level ≥6.5%, fasting glucose ≥7.0 mmol/L, random blood glucose level ≥11.1 mmol/L, a 2-hour oral glucose tolerance test blood glucose level of 11.1 mmol/L or higher, and use of diabetes…”
MethodInfluentialSun, L., Wu, Y., Akinyemi, L. I., Cao, Z., Fan, Z., Liu, H., Yang, Z., Zhang, L., & Zhang, F. (2025) · Cancer Medicine · doi:10.1002/cam4.70777 · Cited by 9
Shi, F., Yang, D., Sun, Q., & Fang, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323887 · Cited by 8
“…if participants exhibited any of the following: triglyceride levels ≥150 mg/dL, total cholesterol ≥200 mg/dL, low-density lipoprotein (LDL) levels ≥130 mg/dL, high-density lipoprotein (HDL) levels ≤50 mg/dL for women and ≤40 mg/dL for men [11], or reported using lipid-lowering medications [12,13].”
Huang, Y., Song, B., Wang, Z., Cheong, K. L., Li, R., Zhao, Q., Chen, J., & Zhong, S. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106724 · Cited by 7
Self-citationLembas, A., Załęski, A., Mikuła, T., Kozłowska, J., & Wiercińska‐Drapało, A. (2025) · IJID Regions · doi:10.1016/j.ijregi.2025.100602 · Cited by 7
“Both HIV infection and unfavorable lipid profiles are associated with systemic inflammation [ 23 , 24 ].”
Metadata
- Authors
- Mahemuti, N., Jing, X., Zhang, N., Liu, C., Li, C., Cui, Z., Liu, Y., & Chen, J.
- Affiliations
- Tianjin Medical University (CN)
- Tianjin Huanhu Hospital (CN)
- Corresponding author
- Chen, Jiageng
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-02-26
- Volume
- 15
- Issue
- 5
- Pages
- 1177
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10004774
- OpenAlex
- W4322503120
- Cited by
- 260
- References
- 52
- Citations by year
- 2026: 37 · 2025: 104 · 2024: 105 · 2023: 14
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tianjin Health Research Project (TJWJ2022QN062, 2021KJ255)
- Tianjin Municipal Education Commission (TJWJ2022QN062, 2021KJ255)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hyperlipidemia, inflammation, inflammatory markers, platelet count, neutrophil-to-lymphocyte ratio, nonlinear relationship, threshold effects, serum lipids, adults
- MeSH terms
- Adult, Cross-Sectional Studies, Humans, Hyperlipidemias, Inflammation, Nutrition Surveys, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.